Curenetics

We're thrilled to announce that Curenetics has been selected to be part of the prestigious KQ Labs cohort 7! 🎉 A huge thank you to @KqLabs for believing in our vision. We're excited to embark on this journey and contribute to the future of data-driven healthcare!

Our founder Sola Adeleke (Curenetics) & more speakers promise to made #PING2024 a must-attend event. linkedin.com/posts/vwv-lawf…

Cureneitcs at the latest Innovate UK-MaRS cohort aims to bring its AI-health-focused breakthroughs to Canada. Learn more about the cohort and their innovative solutions here. linkedin.com/posts/mars-dis…

Thrilled to be a part of one of the Digital Health Launchpad 12 companies that have been chosen are pioneering innovators in the initial stages of developing products or services with significant potential to transform the #NHS and #SocialCare.

Curenetics presented our latest immunotherapy response prediction project at St. George's University Hospital, hosted for 28 medical professors from Hebei Medical University* from China. Thank you for providing us with the opportunity to exchange knowledge!

Curenetics at 'AI for Pharma Growth' with Dr Andree Bates 🎙 In the latest episode E137 of ‘AI for Pharma Growth’ we dive deep into the transformative role of AI in cancer treatment with Sola Adeleke, the founder and CEO of Curenetics. podcasts.apple.com/gb/podcast/e13…

we are especially inspired to see such impactful initiatives fostering collaboration and innovation. We believe in the power of technology to transform cancer care, and it’s exciting to see the PSCC community providing a world-class ecosystem to accelerate these breakthroughs.

We at Curenetics are delighted to be chosen as one of the 10 new start-ups welcomed into the growing community of the Paris Saclay Cancer Cluster (PSCC).

We had great fun recording this series with Dr Ricky Frazer and Dr Anna Olsson-Brown, whose insights and questions brought the conversation to life. Stay tuned, and don’t miss this thought-provoking series, with new episodes released every week! 🎧

🎙️ Big News! 🎙️ 🎄 We’re thrilled to announce that Curenetics will feature in a 4-part Christmas Special of “The Immunobuddies” podcast, launching this Friday, 20th December!

🚀 Exciting news from the Curenetics team! 🧬🔬! We've just launched a new Sway that showcases our latest innovations, including our AI-powered prediction tool and achievements, which are revolutionizing cancer treatment. 🌟Check it out here: [sway.cloud.microsoft/DGrfhs6H7oVOSB…]

Check out our latest video! 🎥 Dive into the exciting world of 'Changing Cancer with AI - Dr Sola Adeleke' and discover Curenetics' AI-driven cancer treatment and our founder's advice on building your own company & entrepreneurship in Africa [youtube.com/watch?app=desk…]

Curenetics is #hiring a Commercialisation Lead! If you're interested in joining our team on our mission to fight cancer please apply via LinkedIn linkedin.com/jobs/view/3889… or Indeed uk.indeed.com/job/commercial…

Exciting news Curenetics Joins Forces with Queen Mary University London & Oracle Cancer Trust in Revolutionary AI-Enabled Oral Cancer Test- qMIDS Supported by NIHR Want to learn more, check out the Oracle Cancer Trust website for a full breakdown. oraclecancertrust.org/breaking-news

Meet our reps Vaishnavi Balaji & Farid Ben Ali. Share insights, and collaborate! Book your personalized meeting by emailing : info@curenetics.io See you there!

Hello Everyone, A friendly reminder about the upcoming @festofbiologics 2023! We're thrilled to be a part of this exciting event from October 10th to 12th at Hall 1, Messe Basel, Stand S13. Don't miss a chance to connect with Curenetics.

To learn more about this exciting venture, check out the official press release on our website media page. curenetics.io #CancerResearch #AI #collaboration

Exciting News! Curenetics joins forces with Queen Mary University London (@QMUL) & Oracle Cancer Trust for a ground-breaking AI-Enabled Oral Cancer Test - qMIDS, supported by NIHR. Want to learn more? Visit the official PCR Test for Oral Cancer website sites.google.com/view/qmids/home